Oral fingolimod (Gilenya) in relapsing MS

Gilenya, or Fingolimod, is the first approved oral disease modifying drug for MS.

Oral fingolimod (Gilenya) in relapsing MS

Postby MSUK » Tue Jul 12, 2011 7:55 am

Oral fingolimod (Gilenya) in relapsing MS: impact on health-related quality of life in a phase II study

Image

Summary: This phase II, placebo controlled study in relapsing MS from Spain reports on the effects of treatment with fingolimod (Gilenya) on patient’s quality of life.

Data from the study supports a clinically important effect of fingolimod on health-related quality of life scores and on the fatigue/thinking HAQUAMS sub-domain. Similarly, BDI-II scores indicative of clinical depression favoured fingolimod over placebo at 6 months.... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1309
MS-UK - http://www.ms-uk.org/
User avatar
MSUK
Family Elder
 
Posts: 2120
Joined: Wed Oct 14, 2009 3:00 pm

Return to Gilenya

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service